Investors Appear Satisfied With Biogened S.A.'s (WSE:BGD) Prospects As Shares Rocket 44%
Jan 20
Have your own idea? Try our Stock Screener
Polish (WIG) Pharma Industry Analysis
UpdatedJan 21, 2025
DataAggregated Company Financials
Companies6
- 7D0.1%
- 3M-12.1%
- 1Y33.9%
- YTD-1.5%
Over the last 7 days, the Pharma industry has remained flat, although notably Molecure gained 7.6%. As for the the longer term, the industry is up 34% over the past 12 months. In the next few years, earnings are forecast to decline by 30% annually.
Industry Valuation and Performance
Has the Polish Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 21 Jan 2025 | zł1.6b | zł318.9m | -zł9,295,998.00 | 43.4x | -175.8x | 5.1x |
| Thu, 19 Dec 2024 | zł1.6b | zł318.7m | -zł9,419,457.00 | 41.9x | -172.4x | 5.1x |
| Sat, 16 Nov 2024 | zł1.6b | zł314.5m | -zł72,767,518.00 | 10.3x | -22.6x | 5.2x |
| Mon, 14 Oct 2024 | zł1.8b | zł314.9m | -zł72,051,939.00 | 10.1x | -25.4x | 5.8x |
| Wed, 11 Sep 2024 | zł1.8b | zł317.3m | -zł60,178,104.00 | 11.5x | -30.5x | 5.8x |
| Fri, 09 Aug 2024 | zł1.8b | zł310.8m | -zł61,217,640.00 | 11.5x | -29.1x | 5.7x |
| Sun, 07 Jul 2024 | zł1.1b | zł310.8m | -zł61,217,640.00 | 11.3x | -18.1x | 3.6x |
| Tue, 04 Jun 2024 | zł1.1b | zł312.1m | -zł61,350,052.00 | 10x | -18.5x | 3.6x |
| Thu, 02 May 2024 | zł1.1b | zł313.6m | -zł43,157,065.00 | 14.7x | -25.9x | 3.6x |
| Sat, 30 Mar 2024 | zł1.2b | zł311.5m | -zł40,173,065.00 | 15.5x | -29.1x | 3.8x |
| Mon, 26 Feb 2024 | zł1.2b | zł311.5m | -zł40,173,065.00 | 15x | -29.8x | 3.8x |
| Wed, 24 Jan 2024 | zł1.1b | zł308.7m | -zł39,880,934.00 | 12.8x | -28.6x | 3.7x |
| Fri, 22 Dec 2023 | zł1.2b | zł308.7m | -zł39,880,934.00 | 11.7x | -29.6x | 3.8x |
| Sun, 19 Nov 2023 | zł1.1b | zł302.0m | -zł45,017,759.00 | 12.4x | -24.5x | 3.7x |
| Tue, 17 Oct 2023 | zł1.1b | zł302.0m | -zł42,933,291.00 | 10.5x | -26.2x | 3.7x |
| Thu, 14 Sep 2023 | zł1.2b | zł287.0m | -zł53,857,118.00 | 11.4x | -22.2x | 4.2x |
| Sat, 12 Aug 2023 | zł1.1b | zł278.4m | -zł53,806,540.00 | 36.1x | -21.3x | 4.1x |
| Mon, 10 Jul 2023 | zł1.1b | zł278.4m | -zł53,806,540.00 | 37.8x | -20.4x | 3.9x |
| Wed, 07 Jun 2023 | zł1.2b | zł282.1m | -zł51,108,194.00 | 35.4x | -23x | 4.2x |
| Fri, 05 May 2023 | zł1.1b | zł276.0m | -zł51,431,989.00 | 9.1x | -21.3x | 4x |
| Sun, 02 Apr 2023 | zł1.1b | zł273.2m | -zł44,427,333.00 | 8.4x | -25.6x | 4.2x |
| Tue, 28 Feb 2023 | zł1.1b | zł273.2m | -zł44,427,333.00 | 8.2x | -24.9x | 4.1x |
| Thu, 26 Jan 2023 | zł1.1b | zł270.3m | -zł44,201,704.00 | 8.1x | -25.9x | 4.2x |
| Sat, 24 Dec 2022 | zł971.4m | zł270.3m | -zł44,201,704.00 | 8x | -22x | 3.6x |
| Mon, 21 Nov 2022 | zł992.1m | zł260.9m | -zł40,809,798.00 | 8.1x | -24.3x | 3.8x |
| Wed, 19 Oct 2022 | zł873.3m | zł260.9m | -zł40,391,998.00 | 9.7x | -21.6x | 3.3x |
| Fri, 16 Sep 2022 | zł1.0b | zł265.6m | -zł29,272,739.00 | 9.3x | -35x | 3.9x |
| Sun, 14 Aug 2022 | zł1.2b | zł263.9m | -zł29,999,209.00 | 12.3x | -39.7x | 4.5x |
| Tue, 12 Jul 2022 | zł1.2b | zł264.2m | -zł29,985,890.00 | 10.4x | -40.1x | 4.6x |
| Thu, 09 Jun 2022 | zł1.4b | zł264.2m | -zł29,985,890.00 | 12.1x | -45.4x | 5.2x |
| Sat, 07 May 2022 | zł1.6b | zł236.1m | -zł2,279,146.00 | 57.9x | -704.3x | 6.8x |
| Mon, 04 Apr 2022 | zł1.8b | zł358.1m | zł72.0m | 13.9x | 25.5x | 5.1x |
| Wed, 02 Mar 2022 | zł1.7b | zł358.1m | zł72.0m | 14x | 23.5x | 4.7x |
| Fri, 28 Jan 2022 | zł2.1b | zł350.0m | zł71.4m | 15.7x | 28.8x | 5.9x |
Price to Earnings Ratio
28.8x
Current Industry PE
- Investors are optimistic on the Polish Pharmaceuticals industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 4.4x is lower than the industry's current PS ratio of 5.1x.
Past Earnings Growth
- Total earnings for the Pharmaceuticals industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 3.0% per year, which is driving profits down.
Industry Trends
Which industries have driven the changes within the Polish Healthcare industry?
| PL Market | 3.85% | |
| Healthcare | 1.00% | |
| Pharma | 0.15% | |
| Pharma | 0.15% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| MOC Molecure | zł9.85 | 6.8% +zł10.6m | -47.3% | PS109x | |
| BGD Biogened | zł26.00 | 8.3% +zł4.9m | 32.0% | PE13.1x | |
| GRZ Green Zebras Spolka Akcyjna | zł13.80 | 3.0% +zł531.1k | n/a | n/a | |
| LCN Labocanna | zł0.34 | 4.0% +zł275.6k | -8.6% | PS17x |